Skip to main content

Pancreatic zymogen activation and protection against autodigestion

Pancreatic zymogens (inactive precursors that cannot yet digest anything) are switched on only in the duodenum, so the gland does not digest itself (autodigestion).

Remember

The proteases (protein-digesting enzymes) leave the pancreas inactive; enteropeptidase in the duodenum starts trypsin, which activates the other zymogens, while packaging, SPINK1 (the pancreas's own trypsin inhibitor) and duct flow protect the gland from early activation.

Memory aid

Think of enteropeptidase as the spark and trypsin as the fire that spreads.

Enteropeptidase is the trigger in the duodenum, and trypsin then spreads the activation to the other pancreatic zymogens.

The pancreas makes enzymes that can digest protein, and the gland is itself made of protein. So its proteases (protein-digesting enzymes), such as trypsinogen and chymotrypsinogen, leave as zymogens, also called proenzymes: inactive precursors that cannot yet digest anything. The ending "-ogen" marks a precursor, so trypsinogen becomes trypsin and chymotrypsinogen becomes chymotrypsin. Amylase (the enzyme that digests starch) and lipase (which digests the triglycerides in dietary fat) are secreted in active form. The proteases are the dangerous ones, since they could digest the gland itself.

Activation is delayed until the enzymes reach the duodenum. There, enteropeptidase (also called enterokinase) turns trypsinogen into trypsin. This enzyme sits on the brush border of duodenal lining cells, a fringe of microscopic projections facing the lumen. Trypsin then activates the other protease zymogens and can also activate more trypsinogen, so a small starter amount of trypsin creates a cascade (a chain reaction). Trypsin activates procolipase too, the inactive precursor of colipase, a helper protein that lipase needs.

Several layered protections keep early trypsin low inside the pancreas. Zymogen packaging stores the enzymes in granules, so they stay inactive. SPINK1 (serine protease inhibitor Kazal type 1) is the pancreas's own trypsin inhibitor and binds and blocks small amounts of trypsin that appear too early. Alkaline fluid flowing through the ducts helps to carry the secretions away. If these safeguards fail, enzymes become active inside the acinar cells (the enzyme-making cells of the pancreas), which causes autodigestion and pancreatitis (inflammation of the pancreas).

Key facts

Zymogens
the proteases, such as trypsinogen and chymotrypsinogen, are released as inactive precursors, while amylase and lipase are secreted in active form.
Trigger
enteropeptidase on the duodenal brush border turns trypsinogen into trypsin.
Cascade
trypsin then activates the other protease zymogens, and it also activates procolipase to release colipase.
SPINK1
the pancreas's own trypsin inhibitor, it binds and blocks trypsin that forms too early inside the gland.
Safeguards
zymogen packaging, SPINK1 and ductal flow limit premature activity.
Failure
early activation inside the acinar cells causes autodigestion and pancreatitis.

Exam traps

  • Amylase and lipase are not zymogens: they are secreted in active form, unlike the proteases, which are the inactive precursors.
  • Enteropeptidase does not activate every zymogen directly, because it acts on only one target, trypsinogen, and it is trypsin that then activates the other protease precursors.
  • SPINK1 does not convert trypsinogen to trypsin inside the gland, because that would be harmful; SPINK1 blocks trypsin that forms too early.

Read the full notes

Tested in 7 SimpleMed+ questions

Practice it in Gastrointestinal System, with the answer and a full explanation after every question.

Practice these questions

Based on 7 SimpleMed+ questions written and peer-reviewed by UK doctors.

Last updated 30 October 2026. For medical education only, not clinical advice.